Your browser doesn't support javascript.
loading
Antitrypanosomal Treatment with Benznidazole Is Superior to Posaconazole Regimens in Mouse Models of Chagas Disease.
Khare, Shilpi; Liu, Xianzhong; Stinson, Monique; Rivera, Ianne; Groessl, Todd; Tuntland, Tove; Yeh, Vince; Wen, Ben; Molteni, Valentina; Glynne, Richard; Supek, Frantisek.
Afiliación
  • Khare S; Department of Genetics and Neglected Diseases, Genomics Institute of the Novartis Research Foundation, San Diego, California, USA.
  • Liu X; Department of Genetics and Neglected Diseases, Genomics Institute of the Novartis Research Foundation, San Diego, California, USA.
  • Stinson M; Department of Pharmacology, Genomics Institute of the Novartis Research Foundation, San Diego, California, USA.
  • Rivera I; Department of Pharmacology, Genomics Institute of the Novartis Research Foundation, San Diego, California, USA.
  • Groessl T; Department of Metabolism and Pharmacokinetics, Genomics Institute of the Novartis Research Foundation, San Diego, California, USA.
  • Tuntland T; Department of Metabolism and Pharmacokinetics, Genomics Institute of the Novartis Research Foundation, San Diego, California, USA.
  • Yeh V; Department of Medicinal Chemistry, Genomics Institute of the Novartis Research Foundation, San Diego, California, USA.
  • Wen B; Department of Pharmacology, Genomics Institute of the Novartis Research Foundation, San Diego, California, USA.
  • Molteni V; Department of Medicinal Chemistry, Genomics Institute of the Novartis Research Foundation, San Diego, California, USA.
  • Glynne R; Department of Genetics and Neglected Diseases, Genomics Institute of the Novartis Research Foundation, San Diego, California, USA.
  • Supek F; Department of Genetics and Neglected Diseases, Genomics Institute of the Novartis Research Foundation, San Diego, California, USA fsupek@gnf.org.
Antimicrob Agents Chemother ; 59(10): 6385-94, 2015 Oct.
Article en En | MEDLINE | ID: mdl-26239982

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Triazoles / Tripanocidas / Enfermedad de Chagas / Parasitemia / Inhibidores de 14 alfa Desmetilasa / Nitroimidazoles Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Antimicrob Agents Chemother Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Triazoles / Tripanocidas / Enfermedad de Chagas / Parasitemia / Inhibidores de 14 alfa Desmetilasa / Nitroimidazoles Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Antimicrob Agents Chemother Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos